Stand Up 2 Cancer has several dream teams organized to help oncology research. Today, I came across an article from UCSC discussing how one of their associate professors in biomolecular engineering, Joshua Stuart (right), is joining as a member of Continue reading Stand Up To Cancer Using Oncology Informatics
Last week was a busy week for The Cardinal. Two days after Dr. Robert Carlson was announced as the new CEO of the National Comprehensive Cancer Network (NCCN), the Indianapolis Star announced that Dr. George Sledge will be leaving Indiana Continue reading Stanford Oncology Informatics
Cefepime Seizure Risk On 6/26/2012, the FDA annouced an a risk for seizure when cefepime is not dose-adjusted for renal dysfunction. The Drug Safety Communication announced the increased seizure risk based on on 59 cases of non-convulsive status epilepticus Continue reading Seizure Risk for Cefepime if not Dose Adjusted
Coffee and medicine go together like … well … coffee and doctors. I have loved coffee at least since medical school – most of us succumb to the peer pressure of drinking coffee while studying medicine. My earliest memory of Continue reading Coffee and Medicine
The short answer is probably not – the randomized control trial is safe for now. The longer answer when it comes to exploring molecular targets in oncology we may need to rethink the double-blind randomized control trial. Since current methods Continue reading End of the Double-Blind Randomized Control Trial?
Ondansetron (Zofran) Prolonged QT On 6/29/2012, the FDA announced an a risk for prolonged QT in patients given the high dose (32mg) ondansetron injection. The Drug Safety Communication announced that the 32mg dose should be avoid and the drug’s label Continue reading Zofran Causes Prolonged QT at High Dose
Oncology Informatics Provides Decision Support Based on Gene Mutations Below is a video introduction to a publicly available project, MyCancerGenome.org, that integrates physician decision support, treatment information, published evidence, and current clinical trials. This is a great example of the Continue reading Oncology Informatics Provides Decision Support Based on Gene Mutations